HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.
about
Piperine enhances carbohydrate/fat metabolism in skeletal muscle during acute exercise in miceDifferential interactions of antiretroviral agents with LXR, ER and GR nuclear receptors: potential contributing factors to adverse eventsAn obese body mass increases the adverse effects of HIV/AIDS on balance and gait.Efficacy of Tat-conjugated ritonavir-loaded nanoparticles in reducing HIV-1 replication in monocyte-derived macrophages and cytocompatibility with macrophages and human neuronsEffects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.Body composition and metabolic changes in HIV-infected patientsAcylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United StatesSkeletal muscle cellular metabolism in older HIV-infected men.Influence of drug transport proteins on the pharmacokinetics and drug interactions of HIV protease inhibitors.Molecular mechanisms for insulin resistance in treated HIV-infection.Naringin prevents HIV-1 protease inhibitors-induced metabolic complications in vivo.Grape seed extract alleviates high-fat diet-induced obesity and heart dysfunction by preventing cardiac siderosis.Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.Changes in plasma lipidome following initiation of antiretroviral therapy
P2860
Q33869171-2842089F-5E00-4B15-B537-0684CDC01028Q35076628-B573B50B-FCD0-4599-8E3E-242DB939C883Q35086013-EDFE34F7-DBC4-482F-9B02-85527A813058Q35145361-7455B9BB-BBE7-4A15-8C4C-62E410DF2351Q35672526-F0B0C7E0-54D4-44F7-8F58-16511FB09CF7Q35949965-36E68A2D-EB06-4394-8E34-C49E263178ACQ36756151-B1F5DD1D-4174-4377-B3F5-E7BD341E2403Q36918744-89B99446-E1D7-47C2-B3A2-C4E20436B988Q37113947-29174DCA-F1ED-4F6C-A230-CC2021D70B59Q37887885-E7913324-6623-4B22-919A-A6991B9CB323Q43865605-0417AD7A-2AD6-4C80-972B-FB1FCBD5EDA7Q46942427-C8EBE9EF-DC00-4B69-A187-4B90CFC2350EQ47121505-B5517007-BCA7-41BD-916A-FDFCEB1217C9Q57167016-1BFD9B9E-E61A-48CB-9E1D-283618E9A3E8
P2860
HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HIV-protease inhibitors suppre ...... CPT1 fatty acid transporters.
@ast
HIV-protease inhibitors suppre ...... CPT1 fatty acid transporters.
@en
type
label
HIV-protease inhibitors suppre ...... CPT1 fatty acid transporters.
@ast
HIV-protease inhibitors suppre ...... CPT1 fatty acid transporters.
@en
prefLabel
HIV-protease inhibitors suppre ...... CPT1 fatty acid transporters.
@ast
HIV-protease inhibitors suppre ...... CPT1 fatty acid transporters.
@en
P2093
P2860
P1476
HIV-protease inhibitors suppre ...... CPT1 fatty acid transporters.
@en
P2093
Michael J Carper
Sasanka Ramanadham
Scott R Richmond
Sheng Zhang
Xiaoyong Lei
P2860
P304
P356
10.1016/J.BBALIP.2010.01.007
P407
P577
2010-02-01T00:00:00Z